{"entity":{"id":"hinova-pharmaceuticals","kind":"company","name":"Hinova Pharmaceuticals","aka":["Hinova Pharmaceuticals Inc."],"tldr":"Hinova Pharmaceuticals is a China-based biotechnology company running 2 late-stage cancer trials of HP518 - Dose Escalation, HP518 -Dose Expansion and HC-1119 in prostate cancer.","summary":"Hinova Pharmaceuticals, based in Chengdu, China, is a biotechnology company listed as 688302.SH. Hinova (also known as Haichuang Pharmaceutical) develops innovative drugs in oncology, metabolic disease and autoimmune/inflammatory conditions, using targeted protein degradation, deuterated-drug and translational medicine platforms. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing HP518 - Dose Escalation, HP518 -Dose Expansion and HC-1119 in prostate cancer. The largest, NCT03851640 (A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)), plans to enrol 417 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.hinovapharma.com"},{"label":"ClinicalTrials.gov: trials led by Hinova Pharmaceuticals","url":"https://clinicaltrials.gov/search?lead=Hinova%20Pharmaceuticals%20Inc."}],"tags":["ctgov-sponsor"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":["nct06155084","nct03851640"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Chengdu","country":"CN","companyType":"biotech","website":"https://www.hinovapharma.com","ticker":"688302.SH","founded":2013,"stage":"public","investors":[],"funding":[]},"route":"/companies/hinova-pharmaceuticals/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}],"trial":[{"id":"nct06155084","kind":"trial","name":"A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients","route":"/trials/nct06155084/"},{"id":"nct03851640","kind":"trial","name":"A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).","route":"/trials/nct03851640/"}]}}